What is clinical endocannabinoid deficiency?

Clinical endocannabinoid deficiency (CEDC) is a proposed spectrum disorder that has been implicated in a range of illnesses, including fibromyalgia, migraine and irritable bowel syndrome. So far, very little research has been conducted on this speculative disorder, but if it is found to exist, it could be responsible for these very common conditions as well as many related ones.

Migraine, serotonin and the blood plasma platelets

The three conditions feature common clinical and biochemical patterns that may point to underlying CEDC. Migraine is thought to be influenced by endocannabinoid function, as areas suspected to be involved with generation of migraines are also affected by cannabinoid activity; furthermore, the endocannabinoid anandamide, with its role in pain modulation and serotonin transmission, is believed to positively affect sufferers of the condition.

Migraine is a debilitating and very common condition that affects millions worldwide

The biochemistry of migraine is highly complex and poorly understood, but it is…

Continue reading at SenseiSeeds.com

About Sensi Seeds

Welcome to the About Sensi Seeds section of the website. Here you can discover the stories behind many different facets of this legendary seed company, from its beginnings as one man’s passion and a small collection of very special seeds to the impact that the Sensi gene bank has had on medicinal marijuana and the culture of cannabis in the Netherlands and beyond. Sensi Seeds has expanded over the last few decades to include sister companies devoted to industrial hemp, to educating the public on the true effects and potential of cannabis, and even to pure relaxation in beautiful surroundings. All branches of the company are founded on the same ethic: it’s not just about Sensi Seeds, it’s about the plant.

Leave a Reply

Your email address will not be published. Required fields are marked *